NCCN Publishes Guidelines for Rare Cancers Associated with Pregnancy

On August 9, the National Comprehensive Cancer Network (NCCN) announced the publication of a new set of guidelines for gestational trophoblastic neoplasia (GTN), also known as gestational trophoblastic disease (GTD), a group of rare cancers that can affect women during pregnancy. GTN can occur when tumors develop in the cells that would normally form the placenta during pregnancy. It affects approximately 1 out of every 1,000 pregnancies in the United States and is more common in many Asian and African countries. The NCCN Guidelines for GTN detail treatments for several variations of the disease.

Read the full NCCN press release here, and download this new guideline here.

Posted 8/9/2018

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington